Buy Gamma Butyrolactone ( GBL ) CAS 96-48-0 - 105756

alp nicotine poches the best smokeless poches ever produce by Carlson

DEMEI #1 Korean hyaluronic acid filler Viscosity // Elasticity / Cohesiveness / Suitable for light wrinkles, lips, eye area 1.0mLx1syr 30Gx1/2(13mm) 2ea   DEMEI #2 Korean hyaluronic acid filler Viscosity /// Elasticity / Cohesiveness // Suitable for marionette lines and deep wrinkles 1.0mLx1syr 27Gx1/2(13mm) 2ea   DEMEI #3 Korean-made hyaluronic acid filler Viscosity / Elasticity /// Cohesiveness /// Suitable for facial contour, forehead , cheekbones, chin, nose and nasolabial folds. When introducing it is desirable to use cannula needles. 1.0mLx1syr 27Gx1/2(13mm) 2ea

Rejeunesse is a sterile viscoelastic gel of 100% cross-linked hyaluronic acid of non-animal origin containing lidocaine. Rejeuness Benefits: hyaluronic acid of non-animal origin - no residual BDDE. prolonged effect. painless procedure. Scope of Rejeunesse Fine: · correction of superficial wrinkles in the periorbital area · correction of creases. fight against mimic wrinkles. Correction of the contour of the lips. Humidification 1 x 1.1 ml syringe per package. Needle size: 30G. Scope of Rejeunesse Deep: · Correction of nasolabial folds, medium and deep wrinkles · Changing the shape and volume of the lips. Intimate plastic. face contour correction. Injection rhinoplasty 1 x 1.1 ml syringe per package. Needle size: 27G. Purpose of Rejeunesse Shape: elimination of deep wrinkles and creases in the forehead, between the eyebrows, nasolabial folds. Modeling the volume of the cheeks and cheekbones. Correction of the contour of the face and neck. replenishment of the lack of volume in the tissues. · Enlargement and alignment of the contours of the lips 1 x 1.1 ml syringe per package. Needle size: 26G. The duration of the effect is from 8 to 12 months. Composition: HA 24 mg/ml, Lidocaine 0.3%.

Celosome presents a series of stabilized hyaluronic acid- (HA)-based fillers.   Scope of Celosome Soft: ·         forehead “worry” and glabellar “frown” lines ·         perioral wrinkles (marionette lines, smoker’s lines, mouth frown) ·         periorbital wrinkles (crow’s feet, fine under-eye lines) ·         nasolabial fold ·         chin crease ·         lip contouring and augmentation The aesthetic effect lasts from 6 to 9 months. 1 syringe × 1.1 ml per pack Product composition: HA, 24 mg/ml, Lidocaine, 0.3%   Scope of Celosome Mid: ·         nasolabial fold ·         forehead and frown lines ·         perioral lines (marionette lines) ·         facelift The aesthetic effect lasts from 9 to 18 months. 1 syringe × 1.1 ml per pack Product composition: HA, 24 mg/ml, Lidocaine, 0.3%   Scope of Celosome Strong: ·         correction of moderate-to-severe wrinkles and folds (nasolabial fold, forehead and frown lines) ·         facial contouring (chin and jawline correction) ·         facelift ·         nose bridge/ridge improvement The aesthetic effect lasts from 12 to 24 months. 1 syringe × 1.1 ml per pack Product composition: HA, 24 mg/ml, Lidocaine, 0.3%   Scope of Celosome Implant: ·         facial contouring (chin, jawline) ·         facial volumization (cheekbones) ·         nose bridge/ridge improvement The aesthetic effect lasts from 12 to 24 months. 1 syringe × 1.1 ml per pack Product composition: HA, 24 mg/ml, Lidocaine, 0.3%

Botulinum Toxin Type A Complex Active Ingredient: Clostridium botulinum toxin type A (Hall strain) Description: a lyophilized white powder for injection in a colorless transparent vial Storage Condition: Store at -15 ~ -5℃ or at 2 ~ 8℃ in a refrigerator, in hermetic container Package Unit: 1 vial Expiry Date: 36 months from the manufacturing date Indication and Usage 1.                     Benign essential blepharospasm in adults aged 18 or more 2.                     To treat foot deformities due to spasticity in pediatric cerebral palsy patients aged 2 or older 3.                     To temporarily improve moderate to severe glabellar lines related to eyebrow wrinkle muscle (corrugator muscle) and/or procerus muscle activity in adults aged from 20 to 65 4.                     Muscle spasticity: upper limb local muscle spasticity related to stroke in adults aged 20 or more 5.                     Treatment of moderate to severe lateral canthal lines associated with orbicularis oculi activity in adult patients 20~65 years of age   6.                     Treatment of cervical dystonia in adult patients, to reduce the severity of abnormal head position and neck pain